As The Jerusalem Post reports, Pluristem uses technology developed by Weizmann and the Technion to develop cell therapies for conditions such as inflammation, muscle injuries, blood disorders – even for “victims of radioactive catastrophes.”
October 20, 2017
Nature reports on the international mission to study Jupiter via NASA’s Juno spacecraft. Juno has now “plumbed the depths of Jupiter,” showing that the “planet’s famous bands of swirling winds” extend quite far down. According to Weizmann’s Dr. Yohai Kaspi, “Determining this is one of the main goals of the Juno mission.”
October 19, 2017
Physics reports that Noam Matzliah, a PhD student in the Weizmann Institute’s Department of Physics of Complex Systems, has “demonstrated a new kind of atom-acting optical force that squeezes a whole cloud of atoms.”
October 19, 2017
Tel Aviv University and Weizmann Institute of Science researchers have shown it is possible to turn mature cells from the heart, brain and other organs in mice models into skin cells. Their findings, just published in the prestigious journal Nature Communications, proves for the first time that it is possible to repurpose the function of different mature cells across the body and harvest new tissue and organs from these cells. “The applications of this are unlimited – from transplants, which would eliminate long waiting lists and eliminate the common problem of immune system rejection of ‘foreign’ organs; to maybe one day curing deafness: taking any cell in the body and transforming it into melanocytes to aid in the restoration of hearing. The possibilities are really beyond the scope of the imagination,” said Prof. Carmit Levy of the TAU Sackler School of Medicine’s human molecular genetics and biochemistry department.
October 19, 2017
Weizmann Institute astrophysicist Dr. Sladjana Knežević led the team that solved an astronomical mystery, showing that a supernova produced high-energy subatomic particles.
October 11, 2017
Prevention covers recent discoveries on the gut microbiome, including important findings from the Weizmann Institute.
October 11, 2017
The gift from Dr. Gladys Monroy and Larry Marks, longtime donors to the Institute, will establish a center for brain research, supporting studies of age-related neurological disorders such as Alzheimer’s and Parkinson’s.
October 10, 2017
Weizmann cryptographer Prof. Shafi Goldwasser is now also heading up Berkeley’s new institute. She recently became only the third woman in history to win a Turing Award.
October 10, 2017
“My intuition tells me that Teva will extricate itself,” Professor Michael Sela, who, together with Ruth Arnon and Deborah Teitelbaum, developed Teva’s blockbuster multiple sclerosis treatment Copaxone at the Weizmann Institute, told “Globes” yesterday.
October 09, 2017
